Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Cadrenal Therapeutics, Inc. (CVKD) $457,414 $1,395,809
2024 Matinas BioPharma Holdings, Inc. (MTNB) $468,000 $589,680
2024 Cadrenal Therapeutics, Inc. (CVKD)
2023 Matinas BioPharma Holdings, Inc. (MTNB) $468,000 $880,603
2022 Matinas BioPharma Holdings, Inc. (MTNB) $450,000 $869,099
2021 Matinas BioPharma Holdings, Inc. (MTNB) $422,300 $1,621,937
2020 Matinas BioPharma Holdings, Inc. (MTNB) $410,000 $1,650,043
2019 Matinas BioPharma Holdings, Inc. (MTNB) $319,444 $752,315
2018 Matinas BioPharma Holdings, Inc. (MTNB)

Recent activity

No earnings-call appearances or filed executive changes recorded yet.